A New Pill Is Being Studied To Treat COVID-19


A COVID-19 pill, meant for treating those sick with the respiratory illness, is being tested in a preliminary study.  Drug makers Merck and Ridgeback Biotherapeutics say it’s a Tamiflu-like pill and it has helped reduced the COVID-19 infection time.  After a five-day treatment, 42-percent of the 182 non-hospitalized participants experienced improvements.  Officials say there were four serious complications, but none related to the pill.  Other studies are being done, so full results are not available yet.

With Virus Aid In Sight, Democrats Debate Filibuster Changes

Previous article

Public Forums Kick Off Search For New STC President

Next article

You may also like